IL6 and prostate carcinoma: Among various causes of prostate cancer androgen receptor (AR) signaling, PTEN/PI3K/AKT/mTOR pathway, IL6/STAT3 and STAT5a/b are the most common pathways involved in prostate cancer cell survival and resistance [433,434].